DMARD non-use in low-income, elderly rheumatoid arthritis patients: results of 86 structured interviews

Table 2 Reasons for DMARD discontinuation among 19 prior-users

	N(%)	Side effects experienced	Physician’s request	Cost	Concerns^a	Inconvenient	Ineffective	Other^b
Methotrexate	10 (52.6)	5	1	2	1	1	2	0
Hydroxychloroquine	6 (31.6)	1	2	0	1	0	2	1
Abatacept	1 (5.3)	0	0	0	0	0	1	0
Etanercept	2 (10.5)	0	0	0	0	0	1	1
Infliximab	1 (5.3)	0	0	0	0	0	1	0
Gold	4 (21.1)	1	1	0	1	0	1	1
Total^c	24	7	4	2	3	1	8	3

^aConcerns about possible side effects or drug reactions that were not already experienced.
^bOther health problems.
^cParticipants were allowed to report more than one DMARD discontinuation.

ISSN: 1478-6362